Breakthrough on a Potential COVID-19 Intellectual Property Rights Waiver [March 25, 2022] [open pdf - 677KB]
From the Document: "On March 15, 2022, the United States [hyperlink], the European Union (EU), India, and South Africa reached agreement on a proposed 'TRIPS' patent waiver for Coronavirus Disease 2019 (COVID-19) vaccines. The Director-General (DG) of the World Trade Organization (WTO) [hyperlink] welcomed the compromise among key players in the debate as a 'major step forward,' [hyperlink] but stressed the need to finalize details. The broader WTO membership is expected to discuss the proposed agreement as WTO decisions generally are by consensus. These developments present issues for Congress including regarding the congressional role, COVID-19 medical incentives and global vaccine access, and U.S. trade policy in advancing intellectual property rights (IPR)."
CRS Insight, IN11901
Congressional Research Service: https://crsreports.congress.gov/